Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hubmann

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
International Archives of Occupational and Environmental Health|January 1, 1995
Carbon disulphide. III. Risk factors for coronary heart diseases in workers in the viscose industryH Drexler, K Ulm, M Hubmann, et al.
Leukemia|December 8, 2010
Monitoring of WT1 expression in PB and CD34(+) donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioningT Lange, M Hubmann, R Burkhardt, et al.
Leukemia Research|November 11, 2011
Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemiaT Ottone, L Cicconi, S K Hasan, et al.
Bone Marrow Transplantation|February 3, 2015
Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphomaA-K Zoellner, S Fritsch, D Prevalsek, et al.
Bone Marrow Transplantation|May 14, 2014
Second haematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantationJ Tischer, N Engel, S Fritsch, et al.
Leukemia|June 11, 2014
Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapseT Köhnke, D Sauter, K Ringel, et al.
Leukemia|December 19, 2017
Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemiaM Rothenberg-Thurley, S Amler, D Goerlich, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
International Archives of Occupational and Environmental Health|January 1, 1995
Carbon disulphide. III. Risk factors for coronary heart diseases in workers in the viscose industryH Drexler, K Ulm, M Hubmann, et al.
Leukemia|December 8, 2010
Monitoring of WT1 expression in PB and CD34(+) donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioningT Lange, M Hubmann, R Burkhardt, et al.
Leukemia Research|November 11, 2011
Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemiaT Ottone, L Cicconi, S K Hasan, et al.
Bone Marrow Transplantation|February 3, 2015
Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphomaA-K Zoellner, S Fritsch, D Prevalsek, et al.
Bone Marrow Transplantation|May 14, 2014
Second haematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantationJ Tischer, N Engel, S Fritsch, et al.
Leukemia|June 11, 2014
Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapseT Köhnke, D Sauter, K Ringel, et al.
Leukemia|December 19, 2017
Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemiaM Rothenberg-Thurley, S Amler, D Goerlich, et al.
Pageof 3